Sysmex Co. (OTCMKTS:SSMXY) Short Interest Update

Sysmex Co. (OTCMKTS:SSMXY) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 900 shares, an increase of 125.0% from the December 31st total of 400 shares. Based on an average daily trading volume, of 216,100 shares, the short-interest ratio is presently 0.0 days.

Sysmex Price Performance

Shares of OTCMKTS SSMXY traded down $0.16 during midday trading on Wednesday, hitting $19.45. The company had a trading volume of 92,957 shares, compared to its average volume of 93,720. The firm has a market capitalization of $12.24 billion, a price-to-earnings ratio of 37.16 and a beta of 0.89. The company has a quick ratio of 2.42, a current ratio of 3.19 and a debt-to-equity ratio of 0.11. Sysmex has a twelve month low of $14.38 and a twelve month high of $28.58. The business has a 50-day simple moving average of $19.30 and a two-hundred day simple moving average of $18.82.

Sysmex (OTCMKTS:SSMXY) last released its earnings results on Wednesday, November 6th. The company reported $0.16 earnings per share (EPS) for the quarter. The company had revenue of $877.31 million during the quarter. Equities research analysts anticipate that Sysmex will post 0.57 earnings per share for the current year.

About Sysmex

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.